Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

New Analysis from Global Industry Analysts Reveals Robust Growth for Glucose Monitoring Devices, with the Market to Reach $15.4 Billion Worldwide by 2026


SAN FRANCISCO, Sept. 28, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Glucose Monitoring Devices - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE
Edition: 16; Released: April 2021
Executive Pool: 7791
Companies: 30 - Players covered include Abbott Diabetes Care, Inc.; ACON Laboratories, Inc.; AgaMatrix, Inc.; Alive Technologies Pty. Ltd.; ARKRAY, Inc.; Ascensia Diabetes Care Holdings AG; B. Braun Melsungen AG; Beurer GmbH; Dexcom, Inc.; GlySens Inc.; LifeScan, Inc.; Medtronic plc; Nova Biomedical Corporation; Omron Healthcare Co., Ltd.; Roche Diagnostics; Senseonics Holdings, Inc.; Terumo Corporation; Trividia Health, Inc.; Ypsomed Holding AG and Others.
Coverage:
 All major geographies and key segments
Segments: Product Type (Testing Strips, Lancets, Blood Glucose Meters, Transmitters & Receivers, Sensors, Lancets); End-Use (Hospitals, Home Care, Diagnostic Centers)
Geographies: 
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlasstm Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global Glucose Monitoring Devices Market to Reach $15.4 Billion by 2026
Amid the COVID-19 crisis, the global market for Glucose Monitoring Devices estimated at US$10.8 Billion in the year 2020, is projected to reach a revised size of US$15.4 Billion by 2026, growing at a CAGR of 5.9% over the analysis period. Testing Strips, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$4.7 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lancets segment is readjusted to a revised 6.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.1 Billion in 2021, While China is Forecast to Reach $3.2 Billion by 2026
The Glucose Monitoring Devices market in the U.S. is estimated at US$3.1 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2026 trailing a CAGR of 8.8% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Blood Glucose Meters Segment to Reach US$2.7 Billion by the year 2026
In the global Blood Glucose Meters segment, USA, Canada, Japan, China and Europe will drive the 5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$2.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. More

MarketGlasstm Platform
Our MarketGlasstm Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyRtm
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: [email protected]

LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp

Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow Us on Twitter
https://twitter.com/marketbytes

Journalists & Media
[email protected]

SOURCE Global Industry Analysts, Inc.


These press releases may also interest you

at 05:05
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:05
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...

at 05:00
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...



News published on and distributed by: